Use of N-acetylglucosamine for the therapy of degenerative joint

Details Use of N-acetylglucosamine for the therapy of degenerative joint Use of N-acetylglucosamine for the therapy of degenerative joint

1989-01-26

1989-09-26

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514825, 536 552, A61K 2700

Patent

active

048700614

ABSTRACT:
The invention refers to the use of N-acetylglucosamine for the therapy of degenerative diseases of the joints and of the connective and the supporting tissues as well as for the therapy of related diseases, wherein the N-acetylglucosamine is administered to the body through buccal absorption.

REFERENCES:
patent: 2538106 (1951-01-01), Kuehl
patent: 2802819 (1957-08-01), Lederer et al.
patent: 3118875 (1964-01-01), Adams
patent: 3683076 (1972-08-01), Rovati
patent: 3697652 (1972-10-01), Rovati et al.
patent: 4006224 (1977-02-01), Prudden
patent: 4181740 (1980-01-01), Zumin et al.
patent: 4216208 (1980-08-01), De Barbieri
patent: 4267313 (1981-05-01), Sannan et al.
patent: 4438117 (1984-03-01), Cherkofsky
patent: 4590067 (1986-05-01), Meisner
patent: 4607025 (1986-08-01), Petitou et al.
patent: 4647453 (1987-03-01), Meisner

Affiliated with

Also associated with

Rating

Use of N-acetylglucosamine for the therapy of degenerative joint does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of N-acetylglucosamine for the therapy of degenerative joint, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-acetylglucosamine for the therapy of degenerative joint will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-187756